Informed decision-making on sympathomimetic use in sport and health

被引:31
作者
Bouchard, R
Weber, AR
Geiger, JD
机构
[1] Univ Manitoba, Fac Med, Div Neurovirol & Neurodegenerat Disorders, St Boniface Res Ctr, Winnipeg, MB R2H 2A6, Canada
[2] Univ Manitoba, St Boniface Res Ctr, Dept Pharmacol, Winnipeg, MB R2H 2A6, Canada
[3] Univ Manitoba, St Boniface Res Ctr, Dept Physiol, Winnipeg, MB R2H 2A6, Canada
[4] Univ Manitoba, St Boniface Res Ctr, Ctr Substance Use Sport & Hlth, Winnipeg, MB R2H 2A6, Canada
来源
CLINICAL JOURNAL OF SPORT MEDICINE | 2002年 / 12卷 / 04期
关键词
ephedrine; ephedra; pseudoephedrine; Ma Huang; amphetamine; caffeine; sports; exercise; athletic performance;
D O I
10.1097/00042752-200207000-00003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The International Olympic Committee, the World Anti-Doping Agency, and International Sport Federations have banned and restricted the use of many stimulants including prescription and over-the-counter medications and dietary supplements. In addition to elite athletes, people of all ages use stimulants in attempts to improve athletic performance, alter body composition, and increase levels of energy. Here we introduce a seven-stage model designed to facilitate informed decision-making by individuals taking or thinking of taking stimulants for sport, health, and/or appearance reasons. We review for amphetamines, over-the counter sympathomimetics, and caffeine their performance-enhancing and performance-degrading effects, health benefits and mechanisms of action, medical side effects, and legal, ethical, safety, and financial implications.
引用
收藏
页码:209 / 224
页数:16
相关论文
共 213 条
[71]  
GEIGER J, IN PRESS DIET BRAIN
[72]   Central nervous system stimulants [J].
George, AJ .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (01) :79-88
[73]   Optimal physical performance in athletes: Key roles of dopamine in a specific neurotransmitter hormonal mechanism [J].
Gilbert, C .
MECHANISMS OF AGEING AND DEVELOPMENT, 1995, 84 (02) :83-102
[74]   Muscular and cardiorespiratory effects of pseudoephedrine in human athletes [J].
Gill, ND ;
Shield, A ;
Blazevich, AJ ;
Zhou, S ;
Weatherby, RP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (03) :205-213
[75]   Pseudoephedrine is without ergogenic effects during prolonged exercise [J].
Gillies, H ;
Derman, WE ;
Noakes, TD ;
Smith, P ;
Evans, A ;
Gabriels, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (06) :2611-2617
[76]   Induction of liver and kidney CYP1A1/1A2 by caffeine in rat [J].
Goasduff, T ;
Dreano, Y ;
Guillois, B ;
Menez, JF ;
Berthou, F .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (12) :1915-1919
[77]  
GOLDING L A, 1963, J Sports Med Phys Fitness, V3, P221
[78]  
GOLDSTEIN A, 1965, J PHARMACOL EXP THER, V150, P146
[79]   Metabolic and exercise endurance effects of coffee and caffeine ingestion [J].
Graham, TE ;
Hibbert, E ;
Sathasivam, P .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (03) :883-889
[80]   CAFFEINE AND EXERCISE - METABOLISM AND PERFORMANCE [J].
GRAHAM, TE ;
RUSH, JWE ;
VANSOEREN, MH .
CANADIAN JOURNAL OF APPLIED PHYSIOLOGY-REVUE CANADIENNE DE PHYSIOLOGIE APPLIQUEE, 1994, 19 (02) :111-138